Showing 15,421 - 15,440 results of 15,701 for search 'treating data', query time: 0.23s Refine Results
  1. 15421

    Home Respiratory Therapies in Patients With Obstructive Sleep Apnea: A Value-based Care Model in Spain by Irene Cano-Pumarega, Candela Caballero-Eraso, Valentín Cabriada, Mar Mosteiro, Juan Fernando Masa, Ferran Barbé

    Published 2025-04-01
    “…This document proposes a value-based care model to improve adherence and health outcomes in patients with obstructive sleep apnea (OSA) treated with CPAP. The current care model for OSA management adopts a uniform, volume-based approach for all patients, limiting personalized care and reducing service quality without providing objective outcome data. …”
    Get full text
    Article
  2. 15422
  3. 15423

    Efficacy and safety of Tongxinluo capsules combined with conventional therapy for acute myocardial infarction: a systematic review and meta-analysis by Dan Ouyang, Dan Ouyang, Xiao Jiang, Hui Wang, Hui Wang, Ma Li Xu, Ma Li Xu, Hang Qi, Xin Hui Li, Xin Hui Li, Jian Zhong Cao

    Published 2025-04-01
    “…BackgroundTongxinluo capsule, a formally classical commercial Chinese polyherbal preparation, has been utilized to treat patients with acute myocardial infarction for decades.Purpose:This meta-analysis aimed to comprehensively evaluate the clinical outcomes of tongxinluo capsule treated acute myocardial infarction.MethodsRandomized controlled trials evaluating the effectiveness of tongxinluo capsule alone or in combination with conventional therapy in patients with acute myocardial infarction were identified from eight major databases: Chinese Biomedical Medicine, China National Knowledge Infrastructure, Wanfang Med Database, China Science and Technology Journal Database, PubMed, and Cochrane Central Register of Controlled Trials. …”
    Get full text
    Article
  4. 15424

    Congenital lung malformations: Do preoperative symptoms have an impact in surgical outcomes? by María López-Díaz, Ester Fernández Díez, Indalecio Cano Novillo, Elena Bergón, Rocío Morante Valverde, Alberto Galindo Izquierdo, Juan L. Antón-Pacheco

    Published 2025-05-01
    “…Patients and methods: Retrospective study of patients with CLM treated with MIS in our hospital between 2003 and 2023. …”
    Get full text
    Article
  5. 15425

    Epidemiological characteristics of medial tibial plateau fractures and effects of two surgical methods for Wahlquist type C fractures by Xu Yunqin, Tang Yong, Deng Pan, Yao Yourong, Wei Qiangqiang, Wang Jianmin

    Published 2025-08-01
    “…Objective: To explore the epidemiological characteristics of medial tibial plateau fractures and compare the clinical outcomes of two surgical methods for Wahlquist type C fractures. Methods: Data of 132 patients with medial tibial plateau fractures who were treated in our hospital from August 1, 2013, to August 1, 2023, were retrospectively collected and analyzed epidemiologically. …”
    Get full text
    Article
  6. 15426

    Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study by Bente Glintborg, Merete Lund Hetland, Tore K Kvien, Brigitte Michelsen, Florenzo Iannone, Karel Pavelka, Ziga Rotar, Maria Jose Santos, Catalin Codreanu, Anne Gitte Loft, Maria Sole Chimenti, Gary J Macfarlane, Gareth T Jones, Mikkel Østergaard, Jakub Zavada, Bjorn Gudbjornsson, Gerður Gröndal, Lykke Midtbøll Ørnbjerg, Adrian Ciurea, Daniela Di Giuseppe, Michael J Nissen, Anabela Barcelos, Irene van der Horst-Bruinsma, Sara Nysom Christiansen, Isabel Castrejón, Sella Aarrestad Provan, Heikki Relas, Simon Horskjær Rasmussen, Ismail Sari, Anna-Mari Hokkanen, Johan K Wallman, Sigrid Vorobjov, Marion Pons, Marleen van de Sande, Corina Mogosan, Lucia Otero-Varela, Karin Laas, Yesim Erez, Katja Perdan Pirkmajer

    Published 2024-09-01
    “…Objectives To compare the treatment effectiveness of secukinumab in radiographic (r) versus non-radiographic (nr) axial spondyloarthritis (axSpA) patients treated in routine care across Europe.Methods Prospectively collected data on secukinumab-treated axSpA patients with known radiographic status were pooled from nine countries.Remission rates based on patient-reported outcomes (PROs; Numeric Rating Scale (0–10), for example, pain ≤2/Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) ≤2 and Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease (ID) <1.3 after 6/12/24 months of secukinumab treatment were calculated.Remission and drug retention rates in r-axSpA versus nr-axSpA patients were compared by logistic and Cox regression models (unadjusted/adjusted for age+sex/adjusted for multiple confounders).Results Overall, 1161 secukinumab-treated patients were included (r-axSpA/nr-axSpA: 922/239). …”
    Get full text
    Article
  7. 15427

    Dynamics of neutralizing antibodies against COVID-19 Omicron subvariants following breakthrough infection in southwest China between December 2022 and April 2024 by Yongquan He, Yi Yin, Yi Zhang, Huiping Yang, Zhiling Jiang, Fang Hao, Taiqiang Zhao, Xiaobin Liu, Yusong Liu, Yong Zeng, Xi Li, Xuemei Chen, Kaiju Xu, Chang Tan, Jie Yang, Li Jiang, Bo Gong, Zhenglin Yang

    Published 2025-07-01
    “…While most COVID-19 patients experienced mild symptoms and were treated as outpatients or at home, some cases progressed to severe illness, necessitating hospitalization or even resulting in death. …”
    Get full text
    Article
  8. 15428
  9. 15429
  10. 15430
  11. 15431

    Results of a non-interventional multicenter observational study on the diagnosis and treatment of patients with axial psoriatic arthritis in rea-world clinical practice in the Russ... by T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. А. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov

    Published 2024-12-01
    “…In 40.5% of patients, axial skeletal involvement in PsA was over-diagnosed due to misinterpretation of clinical and imaging data. The vast majority of patients (77%) were treated with synthetic disease-modifying antirheumatic drugs, mainly methotrexate, which do not affect the activity of spondylitis. …”
    Get full text
    Article
  12. 15432
  13. 15433

    The role of irregular eating behaviors in metabolic dysfunction-associated steatotic liver disease: evidence from a multicenter cross-sectional study in China by Xingxing Ren, Miao Zhang, Xiaoyang Sun, Lili Zheng, Yufang Bi, Qiang Li, Lirong Sun, Fusheng Di, Yushan Xu, Dalong Zhu, Yanyan Gao, Yuqian Bao, Yao Wang, Lanjie He, Xin Gao, Jian Gao, Mingfeng Xia, Hua Bian

    Published 2025-08-01
    “…Methods In this multicenter cross-sectional study, we analyzed data from 1965 adults recruited from diabetes, obesity, and metabolic disease clinics in six municipalities/provinces in China. …”
    Get full text
    Article
  14. 15434

    Clinical manifestations and prognosis of giant cell arteritis: A retrospective cohort study by E. E. Filatova, N. M. Bulanov, A. D. Meshkov, O. O. Borodin, I. O. Smitienko, E. V. Chachilo, A. A. Nartov, A. L. Filatova, A. V. Naumov, P. I. Novikov, S. V. Moiseev

    Published 2024-01-01
    “…GCs therapy was performed in all patients who agreed to be treated (n=158), methotrexate was used in 49 out of 158 patients, leflunomide – in 9 patients. …”
    Get full text
    Article
  15. 15435

    CRISPR/Cas9-mediated knockout of SLC15A4 gene involved in the immune response in bovine rumen epithelial cells by Mao-cheng JIANG, Zi-xuan HU, Ke-xin WANG, Tian-yu YANG, Miao LIN, Kang ZHAN, Guo-qi ZHAO

    Published 2023-10-01
    “…In order to gain further insight into the potential function of SLC15A4, we utilized transcriptome data, which revealed a change in the genes between WT-BRECs and SLC15A4-KO. …”
    Get full text
    Article
  16. 15436

    The Efficacy and Safety of Tolvaptan in Heart Failure Patients with Congestive Signs: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Mei Zeng, Na Li, Tongshuai Chen, Yun Ti, Chunmei Zhang, Peili Bu

    Published 2023-03-01
    “…The PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched to collect data from all randomized controlled trials (RCT) examining the efficacy and safety of tolvaptan in heart failure patients with congestive signs compared with placebo or blank control until March 4, 2021. …”
    Get full text
    Article
  17. 15437

    S1PR4-dependent effects of Etrasimod on primary human myeloid immune cell activation by Fiona K. Sailer, Megan A. Palmer, Blerina Aliraj, Jan Heering, Jan Heering, Andreas Brockmann, Mohammed A. F. Elewa, Mohammed A. F. Elewa, Aissa Röhrig, Aissa Röhrig, Ewgenij Proschak, Ewgenij Proschak, Ewgenij Proschak, Dariusz T. Stepniak, Simeon Ramsey, Bernhard Brüne, Bernhard Brüne, Andreas Weigert

    Published 2025-04-01
    “…Regarding receptor dynamics, we show that Etrasimod induces internalization of S1PR4.ConclusionTaken together, our data show that S1PR4 takes on an essential role in the regulation of various immunological functions, and that Etrasimod can act as a superagonist/functional antagonist of S1PR4.…”
    Get full text
    Article
  18. 15438

    Infrapyloric lymph node dissection for colon cancer of hepatic flexure in laparoscopic extended right hemicolectomy with D3 lymph node dissection of right colon cancer by Yi Xiaojiang, Feng Xiaochuang, Li Hongming, Liao Weilin, Lu Xinquan, Wang Jiahao, Lin Jiaxin, Diao Dechang

    Published 2022-06-01
    “…[Objectives] To summerize the clinical data of patients with colon cancer of hepatic flexure underwent infrapyloric lymph node dissection in laparoscopic extended right hemicolectomy with D3 lymph node dissection of right colon cancer, aiming to provide reference for clinical diagnosis and treatment. …”
    Get full text
    Article
  19. 15439

    Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing by Xuefeng Wang, Paulo C Rodriguez, Frederick L Locke, Xiaoqing Yu, Marco L Davila, Salvatore Corallo, Bijal Shah, Kayla Reid, Michael D Jain, Sean J Yoder, Chaomei Zhang, Reginald Atkins, Meghan A Menges, Ling Cen, Jerald D Noble, Turab J Mohammad, Christina A Bachmeier, Samira Naderinezhad, Lanmin Zhang, Julieta Abraham Miranda, Julio C Chavez, Rebecca S Hesterberg, Luis Cuadrado Delgado, Constanza Savid-Frontera, John L Cleveland

    Published 2025-07-01
    “…Prolonged time in expansion culture, as used during tisa-cel manufacturing, greatly decreased naïve and central memory T-cell subsets.Conclusions Following manufacture, axi-cel is less differentiated and has greater immune activation compared with tisa-cel, potentially accounting for its greater efficacy and toxicity in patients. Our data support the conclusion that tisa-cel is adversely affected by its manufacturing rather than by the CAR construct.…”
    Get full text
    Article
  20. 15440

    Moving Beyond G‐CSF Mobilization—Learning From a 15‐Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma by Sumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, Anant Gokarn, Nishant Jindal, Akanksha Chichra, Lingaraj Nayak, Sumathi Hiregoudar, Minal Poojary, Suryatapa Saha, Sarika Parab, Shashank Ojha, Prashant Tembhare, Nikhil Patkar, Sweta Rajpal, Gaurav Chatterjee, Libin Mathew, Papagudi Subramanian, Navin Khattry

    Published 2025-07-01
    “…ABSTRACT Background Stem‐cell mobilization in multiple myeloma is usually done with G‐CSF with or without Cyclophosphamide (Cy) based chemotherapy/Plerixafor. Pre‐clinical data suggest the role of proteasome inhibitors in mobilization. …”
    Get full text
    Article